This inventor holds 1 USPTO granted patent. Top assignee: Penumbra, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Inventor Evan T. Koretsky: Pioneering Advancements in Medical Catheter Technology
Introduction
Evan T. Koretsky is an innovative inventor based in San Francisco, CA. He has made significant contributions to the field of medical technology through his invention focused on infusion catheters. With one patent to his name, Koretsky exemplifies the spirit of invention and the drive towards improving healthcare solutions.
Latest Patents
Koretsky holds a patent for an "Infusion Catheter and Methods of Use." This groundbreaking invention describes venous infusion catheter assemblies designed to enhance the delivery of fluids within a patient's body. The catheter assembly features an elongated body with a proximal and distal end, along with an expandable occlusion element. It includes two infusion lumens, one leading to a proximal infusion port to regulate the flow of hypothermic fluid to the patient's cerebral vasculature, and another extending to a distal infusion port, which directs normothermic or hyperthermic fluid towards the heart. Additionally, the catheter may incorporate a suction lumen to facilitate blood draw when introduced into the vasculature.
Career Highlights
Evan T. Koretsky is currently employed at Penumbra, Inc., a company renowned for its focus on innovative medical devices. His role at Penumbra has allowed him to further develop his ideas and implement technological advancements in the medical field.
Collaborations
Throughout his career, Koretsky has collaborated with talented individuals such as Robert D. Schultz and Justin M. Olshavsky. These partnerships demonstrate the value of teamwork in pursuing innovations that push the boundaries of existing medical technology.
Conclusion
Evan T. Koretsky's contributions to the world of medical device innovation are noteworthy. His focus on enhancing patient care through his patented infusion catheter reflects his dedication to improving healthcare solutions. As he continues his work at Penumbra, Inc., the medical community eagerly anticipates further advancements that stem from his inventive spirit.